Beyond CDMO

We are more than a CDMO; we are pioneers and partners in the truest sense. At NorthX Biologics, we believe in embarking on a collaborative journey with our clients, navigating the complexities of biologics and growing along the way. We are beyond the typical biologics CDMO, we are more. Let's journey together to turn visionary science into life-changing treatments.

Our expertise spans biologics, including plasmid DNA, mRNA, proteins, virus and viral vectors, cell therapy, and an array of advanced therapeutic modalities.

Our complete CMC Services

We can support your project from concept through to commercial manufacturing. Our speed and flexibility allow for rapid program design and execution to overcome development challenges.

At NorthX Biologics we have a proven track record of developing early-stage processes into manufacturing processes suitable for clinical applications and on to commercialization. We understand the need for different levels of process performance and analytical control through pre-clinical and clinical development stages. Irrespectively if your product is a pDNA, protein or any other advanced biologic, we support you all the way.

At NorthX Biologics, we provide an extensive range of testing services tailored to the advanced products we manufacture. Our expertise encompasses most biologics, such as RNA/DNA, recombinant proteins and enzymes, peptides, and particle-based vaccines (OMVs, LNPs etc.). ​

At NorthX Biologics, we’re proud to offer a wide spectrum of protein production services, specializing in recombinant proteins. Our experienced team of scientists can take your gene sequence through gene cloning, cell bank generation, protein expression to final isolation and purification. We work with a range of expression systems and cell types – from microbial to mammalian – ensuring optimal protein expression level for your target protein.

We are BSL 2+ and 3 certified and can handle any virus or viral vector that you may need. We support cell and gene therapy (CGT) projects from pre-clinical through to commercial manufacture. and can produce Adeno-associated virus (AAV), Adenovirus (AV), Lentivirus (LV) Arenavirus, Flavivirus, and retrovirus (RV) for GMP and non GMP applications. We pair this with our Process and analytical development and plasmid DNA supply in order to give our clients a simple and fast approach to CGT applications.

We are experts in the production of plasmid DNA and can support your project from pre-clinical through to commercial manufacture. We offer plasmid DNA to the right quality at the right time, no matter if you are working with DNA vaccines, viral vector gene therapies, mRNA or any other modalities.

NorthX Biologics offers a full suite of services designed to optimize your cell therapy products’ development, production, and delivery. We’re here to support your mission of bringing life-changing therapies to patients in need. We specialize in various cell types, including dendritic, stem and IPSC.

At NorthX Biologics, we provide state-of-the-art mRNA development and production services, helping our clients navigate the rapidly evolving landscape of mRNA-based therapeutics. Our range of services encompasses every step of the process from initial development to final aseptic fill/finish, ensuring a consistent, high-quality product, whether for research and development (R&D) or good manufacturing practice (GMP) applications.

At NorthX Biologics, we are dedicated to providing industry-leading solutions for the pharmaceutical and biotech sectors. With our cutting-edge technology and unwavering commitment to quality, we offer exceptional aseptic fill/finish services that meet the highest standards in the industry.

Lab staff portrait
Lab staff portrait

The people of NorthX

At NorthX Biologics, we go beyond the traditional role of a CDMO. We are Beyond CDMO, and this commitment is exemplified by our exceptional team and innovative solutions. Our mission is to support your project with the expertise, dedication, and care that you deserve. Discover how our cutting-edge technologies, experienced professionals, and comprehensive services can propel your project to new heights. Learn more about us, our people, and how we can help you achieve your goals.

Man in production clothes working on filling machine

Why work with NorthX?

When working with a CDMO, it’s important to have a strong foundation to work from. Let us show you why you should work with us.

Small and experienced – Our team of 100+ people are used to direct communication with SMEs and have years of experience to support your programs.
Support and innovation – We are a recognized Innovation Hub with the capability and mandate to help innovative projects with process development and scale-up.
Reliability – We offer fast and flexible service in development and production.

NorthX Biologics headquarters

Come visit us

We offer two facilities to support your advanced biologic.  Our headquarters is located in Matfors, Sweden and our second site is located close to the center of Stockholm.  Come visit us and see why we are Beyond CDMO.

Discover more

Amarna Therapeutics partners with NorthX Biologics to advance Nimvec™ AM510 gene therapy development

Amarna Therapeutics partners with NorthX Biologics to advance Nimvec™ AM510 gene therapy development

Amarna Therapeutics, a privately held biotechnology company specializing in transformative gene therapies, is pleased to announce its strategic collaboration with NorthX Biologics, a leading biologics manufacturing partner. This partnership represents ...

Neogap Therapeutics partners with NorthX Biologics to advance scalable manufacturing for its novel cancer cell therapy

Neogap Therapeutics partners with NorthX Biologics to advance scalable manufacturing for its novel cancer cell therapy

Neogap Therapeutics, a Swedish clinical-stage biotechnology company, has entered a strategic collaboration with NorthX Biologics, a leading CDMO, to advance manufacturing strategies for Neogap’s personalised cancer cell therapy. Supported by ...

NorthX Biologics Innovation Hub supports Abera Bioscience with nasal pneumococcal vaccine

NorthX Biologics Innovation Hub supports Abera Bioscience with nasal pneumococcal vaccine

Abera Bioscience AB (“Abera” or “the Company”) has been awarded a 1 million SEK grant from Vinnova to advance the development of its innovative pneumococcal vaccine, Ab-01.12, towards clinical trials. ...

Let’s journey together

NorthX Biologics is dedicated to the journey of complex biologics. Let us know how we can help move your product forward.